News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ArcticDx Inc. Unveils Pharmacogenetic Testing for Ocular Vitamin Therapy at ASRS



8/26/2013 7:52:02 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ArcticDx, Inc. announced that its Vita RiskTM pharmacogenetic analysis, which supports the genotype-directed selection of appropriate eye vitamin therapies for patients suffering from age-related macular degeneration (AMD), will be available as part of the new Macula RiskĀ® PGx test launched at the ASRS meeting.

Hey, check out all the research scientist jobs. Post your resume today!

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES